The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - PharmaMar; Tecnofarma
Consulting or Advisory Role - GlaxoSmithKline; PharmaMar
Research Funding - Adaptimmune (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb/Pfizer (Inst); Celgene (Inst); Deciphera (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Phase II trial of palbociclib in advanced sarcoma overexpressing CDK4 gene excluding dedifferentiated liposarcoma (DD LPS): A study from the Spanish Group for Research on Sarcoma (GEIS).
 
Javier Martin Broto
Honoraria - Bayer; Eisai; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Tecnofarma
Consulting or Advisory Role - Amgen; Asofarma; Bayer; GlaxoSmithKline; Lilly; Novartis; PharmaMar; Roche; Tecnofarma
Speakers' Bureau - PharmaMar
Research Funding - Amgen (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Eisai; Eisai (Inst); FORMA Therapeutics (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Nektar (Inst); Novartis; Novartis (Inst); Pfizer (Inst); PharmaMar
Expert Testimony - Novartis; PharmaMar
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Jeronimo Martinez Garcia
No Relationships to Disclose
 
David Silva Moura
Honoraria - Tecnofarma
Research Funding - Eisai (Inst); Immix BioPharma (Inst); Novartis (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Bayer; Celgene; Eisai; Pfizer; PharmaMar
 
Andres Redondo
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar
Research Funding - Eisai (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar
 
Antonio Gutierrez
Consulting or Advisory Role - Abbvie; AstraZeneca Spain; Incyte; Janssen; Takeda
Speakers' Bureau - Abbvie; AstraZeneca Spain; Janssen; Takeda
 
Antonio Lopez-Pousa
No Relationships to Disclose
 
Javier Martinez-Trufero
Consulting or Advisory Role - Eisai; PharmaMar
Research Funding - Blueprint Medicines (Inst); Lilly (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Merck; PharmaMar
 
Isabel Sevilla
Consulting or Advisory Role - Amgen; Ipsen; Pfizer; PharmaMar
Speakers' Bureau - AAA HealthCare; Ipsen; PharmaMar; Pierre Fabre; Sanofi
Travel, Accommodations, Expenses - Ipsen
 
Robert Diaz Beveridge
No Relationships to Disclose
 
Maria Pilar Solis-Hernandez
Honoraria - Ipsen; Kern Pharma; Merck; MSD Oncology; Roche
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Ipsen; Kern Pharma; Leo Pharma; Lilly; MSD Oncology; Pfizer; PharmaMar; Pierre Fabre; Roche
 
Amancio Carnero
No Relationships to Disclose
 
Marco Perez
No Relationships to Disclose
 
David Marcilla
No Relationships to Disclose
 
Jose A. Lopez-Martin
Employment - Pharmamar-zeltia
Stock and Other Ownership Interests - PharmaMar
Consulting or Advisory Role - Amgen; Amgen; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Caris Life Sciences; Celgene; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche; Roche Molecular Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; MSD Oncology; Roche; Roche
 
Antonio Casado Herraez
Consulting or Advisory Role - Eisai; Eisai; Merck Sharp & Dohme; PharmaMar; Roche
Research Funding - Pharmamar (Inst)
Travel, Accommodations, Expenses - Lilly; Pharmamar; Roche
Other Relationship - Lilly (Inst)
 
Rosa Maria Alvarez Alvarez
Honoraria - Bristol-Myers Squibb; PharmaMar; Roche/Genentech
Consulting or Advisory Role - GlaxoSmithKline; Lilly; Novartis; PharmaMar; Roche/Genentech
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); CEBIOTEX (Inst); Janssen Oncology; MSD Oncology (Inst); Novartis; PharmaMar (Inst); Rain Therapeutics; Roche/Genentech; Takeda (Inst)
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Josefina Cruz Jurado
Consulting or Advisory Role - AstraZeneca; Bayer; DAICHII; GlaxoSmithKline; Lilly; Novartis; Pfizer; PharmaMar; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; Novartis; Pfizer; PharmaMar; Roche
Travel, Accommodations, Expenses - Novartis; PharmaMar
 
Anna Estival-Gonzalez
Honoraria - AstraZeneca Spain; Bayer; MSD Oncology; PharmaMar; Roche; Takeda
Speakers' Bureau - AstraZeneca Spain; MSD Oncology
Travel, Accommodations, Expenses - Lilly; Pfizer
 
Patricio Ledesma
No Relationships to Disclose
 
Nadia Hindi
No Relationships to Disclose